Literature DB >> 11268337

CXC chemokine receptors expression during chronic relapsing experimental autoimmune encephalomyelitis.

A R Glabinski1, S O'Bryant, K Selmaj, R M Ransohoff.   

Abstract

Chemokines are small proinflammatory cytokines that possess the ability to stimulate migration of inflammatory cells towards the tissue site of inflammation. Previous reports showed that several chemokines may be involved in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of autoimmune central nervous system (CNS) inflammation. Inflammatory cells respond to chemotactic chemokine gradient through the chemokine receptors (ChRs). The goal of this study was to analyze expression of ChRs belonging to CXC subfamily during different stages of chronic relapsing EAE. We found significantly increased expression of CXCR2 and CXCR4 in the spinal cord during the first and second disease attacks. The kinetics of this expression in CNS and blood suggests that CXCR2 is expressed by leukocytes migrating from the blood, but CXCR4 is expressed mainly by CNS parenchymal cells. Those results support the interpretation that chemokine-chemokine receptor interactions may play an important role in the development of CNS autoimmune inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11268337     DOI: 10.1111/j.1749-6632.2000.tb05377.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

3.  Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.

Authors:  Stylianos Ravanidis; Kyriaki Nepheli Poulatsidou; Roza Lagoudaki; Olga Touloumi; Elena Polyzoidou; Athanasios Lourbopoulos; Evangelia Nousiopoulou; Paschalis Theotokis; Evangelia Kesidou; Dimitrios Tsalikakis; Dimitrios Karacostas; Maria Grigoriou; Katerina Chlichlia; Nikolaos Grigoriadis
Journal:  Stem Cells Transl Med       Date:  2015-10-28       Impact factor: 6.940

4.  Regulation of neuronal P53 activity by CXCR 4.

Authors:  Muhammad Z Khan; Saori Shimizu; Jeegar P Patel; Autumn Nelson; My-Thao Le; Anna Mullen-Przeworski; Renato Brandimarti; Alessandro Fatatis; Olimpia Meucci
Journal:  Mol Cell Neurosci       Date:  2005-09       Impact factor: 4.314

Review 5.  CXCR2 Signaling and Remyelination in Preclinical Models of Demyelination.

Authors:  Dominic D Skinner; Thomas E Lane
Journal:  DNA Cell Biol       Date:  2019-12-17       Impact factor: 3.311

6.  Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC.

Authors:  Bartosz Bielecki; Andzelika Mazurek; Paweł Wolinski; Andrzej Glabinski
Journal:  J Clin Immunol       Date:  2007-10-25       Impact factor: 8.317

7.  CXCR4 receptors in the dorsal medulla: implications for autonomic dysfunction.

Authors:  Gerlinda E Hermann; Montina J Van Meter; Richard C Rogers
Journal:  Eur J Neurosci       Date:  2008-02       Impact factor: 3.386

8.  Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis.

Authors:  Natalia M Moll; Michael B Cossoy; Elizabeth Fisher; Susan M Staugaitis; Barbara H Tucky; Anna M Rietsch; Ansi Chang; Robert J Fox; Bruce D Trapp; Richard M Ransohoff
Journal:  Arch Neurol       Date:  2009-01

9.  CXCL12 sensitizes vago-vagal reflex neurons in the dorsal medulla.

Authors:  Richard C Rogers; Edouard Viard; Gerlinda E Hermann
Journal:  Brain Res       Date:  2012-11-23       Impact factor: 3.252

10.  Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain.

Authors:  Khalid Benamar; Menachem Yondorf; Ellen B Geller; Toby K Eisenstein; Martin W Adler
Journal:  Br J Pharmacol       Date:  2009-06-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.